Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xeris Biopharma Holdings (XERS) Tax Rate (2022 - 2024)

Historic Tax Rate for Xeris Biopharma Holdings (XERS) over the last 3 years, with Q3 2024 value amounting to 17.44%.

  • Xeris Biopharma Holdings' Tax Rate rose 147400.0% to 17.44% in Q3 2024 from the same period last year, while for Jun 2025 it was 9.41%, marking a year-over-year increase of 102300.0%. This contributed to the annual value of 3.97% for FY2024, which is 20000.0% up from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Tax Rate stood at 17.44% for Q3 2024, which was up 147400.0% from 5.25% recorded in Q2 2024.
  • In the past 5 years, Xeris Biopharma Holdings' Tax Rate ranged from a high of 17.44% in Q3 2024 and a low of 5.25% during Q2 2024
  • For the 3-year period, Xeris Biopharma Holdings' Tax Rate averaged around 2.48%, with its median value being 1.63% (2023).
  • Data for Xeris Biopharma Holdings' Tax Rate shows a peak YoY increase of 147400bps (in 2024) and a maximum YoY decrease of -85400bps (in 2024) over the last 5 years.
  • Over the past 3 years, Xeris Biopharma Holdings' Tax Rate (Quarter) stood at 2.55% in 2022, then crashed by -32bps to 1.73% in 2023, then skyrocketed by 907bps to 17.44% in 2024.
  • Its last three reported values are 17.44% in Q3 2024, 5.25% for Q2 2024, and 1.64% during Q1 2024.